ArticleImmunogenetics2023

Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expression.

Xianglai Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.